Arcataur Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Buy
1,779
+25
+1% +$8.56K 0.16% 55
2026
Q1
$617K Sell
1,754
-3
-0.2% -$1.07K 0.17% 55
2025
Q4
$575K Sell
1,757
-5
-0.3% -$1.59K 0.16% 59
2025
Q3
$497K Buy
1,762
+73
+4% +$21.2K 0.15% 61
2025
Q2
$472K Hold
1,689
0.15% 63
2025
Q1
$526K Sell
1,689
-67
-4% -$19.8K 0.18% 58
2024
Q4
$458K Hold
1,756
0.15% 66
2024
Q3
$566K Sell
1,756
-2
-0.1% -$654 0.19% 51
2024
Q2
$549K Sell
1,758
-10
-0.6% -$2.94K 0.2% 50
2024
Q1
$503K Hold
1,768
0.18% 53
2023
Q4
$509K Sell
1,768
-10
-0.6% -$2.73K 0.19% 45
2023
Q3
$478K Hold
1,778
0.2% 49
2023
Q2
$395K Buy
+1,778
New +$413K 0.16% 62

Other funds holding AMGN

Arcataur Capital Management's AMGN Position: Q2 2026 in Review

Arcataur Capital Management increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $8.56K and bringing the position to 1,779 shares worth $644K. The position accounts for 0.16% of the portfolio, ranked #55.

Arcataur Capital Management first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Arcataur Capital Management held 1,779 shares of Amgen worth $644K as of Q2 2026.
  • Arcataur Capital Management bought 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.16% of Arcataur Capital Management's portfolio in Q2 2026, its #55 holding.
  • Arcataur Capital Management first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.